Inventaire - your friends and communities are your best library

Pathogenesis of human B cell lymphomas

published in: Annual Review of Immunology

date of publication: 2012-01-06

main subject: pathogenesis

Cites articles 200

Too many entities requested (367). Only 200 are displayed.

Date

Title

Authors

2011-07-29

The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia

Hagop Kantarjian, William G Wierda, Susan O'Brien, Michael J. Keating, Jan A Burger, Julia Hoellenriegel, Mariela Sivina, Neill A Giese, Langdon L Miller, Brian J Lannutti
2011-04-01

Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1

Alexandar Tzankov
2011-01-01

Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation

Xavier Sagaert, Peter Van Loo
2011-06-23

The molecular pathogenesis of primary mediastinal large B-cell lymphoma

Randy D Gascoyne
2011-08-18

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

Martin Hirst, Yaron Butterfield, Angela Brooks-Wilson, Eric Y Zhao, Malachi Griffith, Andrew Mungall, Joseph M Connors, Randy D Gascoyne, Lisa M Rimsza, Ryan D Morin, Tesa M Severson, John J Spinelli, Marco Marra, Douglas Horsman, Susana Ben-Neriah, Sanja Rogic, Merrill Boyle, Allen Delaney, Rodrigo Goya, Richard Corbett, Readman Chiu, Shaun Jackman, Martin Krzywinski, Diane L Trinh, Duane E. Smailus, Michelle Moksa, Bruce W Woolcock, Yongjun Zhao, Kane Tse, Inanc Birol, Jacqueline E. Schein
2011-03-29

T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1.

Petra Van Damme, Kris Gevaert, Yasmine Driege, Jens Staal, Rudi Beyaert
2011-02-25

Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response

Baidong Hou, Martin F. Bachmann, Philippe Saudan
2011-08-01

Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia
2011-01-14

The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma

Sylvain Mareschal, Lucile Couronné
2011-06-16

BRAF mutations in hairy-cell leukemia

Laura Pasqualucci, Francesco Forconi, Giorgio Inghirami, Gianluca Schiavoni, Paolo Sportoletti, Luca Arcaini, Raúl Rabadán, Francesco Di Raimondo, Livio Trentin, Brunangelo Falini, Pellegrino Musto, Gianpietro Semenzato, Torsten Haferlach, Claudia Haferlach, Susanne Schnittger, Robin Foà, Stefano A Pileri, Enrico Tiacci, Maria Paola Martelli, Arcangelo Liso, Laurent Farinelli, Valentina Pettirossi
2011-03-17

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

Louis M Staudt, Ujunwa C Okoye, Pedro Farinha, Anke van den Berg, Steven Jones, Randy D Gascoyne, Joseph M Connors, Lisa M Rimsza, Sohrab P Shah, Marco Marra, Kerry J Savage, Douglas Horsman, Christian Steidl, Lixin Rui, Susana Ben-Neriah, Bruce W Woolcock, Yongjun Zhao, Adele Telenius, Arjan Diepstra
2011-09-26

Targeting MYC dependence in cancer by inhibiting BET bromodomains

Barbara Bryant
2011-07-31

Analysis of the coding genome of diffuse large B-cell lymphoma

Monica Messina, Raúl Rabadán, Charles G. Mullighan, Govind Bhagat, Laura Pasqualucci, Gianluca Gaidano, Gianluca Gaidano, Riccardo Dalla-Favera, Annalisa Chiarenza, Amy Chadburn, Giulia Fabbri
2011-08-03

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

Johannes Zuber, Harald Herrmann, Peter Valent, Christopher R. Vakoc, Katharina Blatt
2011-01-01

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia

Amelia Cimmino, Gerardo Musuraca, Nicola Valeri, Ivan Vannini, Deepa Sampath, Massimo Negrini, Carlo Maria Croce, George A. Calin, Muller Fabbri, Michael J. Keating, Neil E Kay
2010-09-17

The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence

Maoyi Lai, Michelle Chen
2010-08

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer

Mads Gyrd-Hansen, Pascal Meier
2010-12-01

BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma

Govind Bhagat, Klaus Rajewsky, Laura Pasqualucci
2010-10-12

The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia

Maryalice Stetler-Stevenson, Stefania Pittaluga, Wyndham H. Wilson
2010-08-26

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Antoni Ribas, Igor Puzanov, Grant McArthur, Keith Flaherty
2010-11-01

BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy

Gabriela Chiosis, Eloisi Caldas-Lopes, Ryan D Morin, Maria E Figueroa, Leandro Cerchietti, Randy D Gascoyne
2010-09-30

Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.

Carolyn J. Brown, Randy D Gascoyne, Joseph M Connors, Sohrab P Shah, Ryan D Morin, Tesa M Severson, Marco Marra, Kerry J Savage, Douglas Horsman, Christian Steidl, Susana Ben-Neriah, Jacqueline E. Schein, Adele Telenius, Thomas Relander, John Kwok-Cheung Chan
2010-11-24

Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response

Chris Benner, Ronald M. Evans
2010-01-01

Regulation of adaptive immunity by the innate immune system

Ruslan Medzhitov, Akiko Iwasaki
2010-06-11

Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma

Ralf Küppers, Reiner Siebert
2010-11-18

Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity

Owen A O'Connor, Wyndham H. Wilson, Ann S LaCasce, Kieron Dunleavy
2010-07-06

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

Douglas H Thamm
2010-08-04

Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1.
2010-04-01

A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo

Leandro Cerchietti, Jose M Polo, Cheryl Arrowsmith, Alex MacKerell, Gilbert G Privé
2010-07-01

MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1.

Theresa L Geiger, Dinesh S Rao, David Baltimore
2010-10-12

Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era

Martin Dreyling
2010-07-13

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma

Michael Green, Stefano Monti, Przemysław Juszczyński, Todd Golub, Donna Neuberg, Margaret A Shipp

Article - wd:Q34245261

Welcome to Inventaire

the library of your friends and communities

learn more